Abstract
Mucociliary clearance is an important physiological defense mechanism of the respiratory tract to protect the body against noxious inhaled materials. This process is responsible for the rapid clearance of nasally administered drugs from the nasal cavity to the nasopharynx, thereby interfering with the absorption of drugs following intranasal application. This review describes the mucociliary system and the methods used for its characterization. Examples are given of the effects of drugs and additives on its functioning. Further, possible approaches are presented for increasing the residence time of drugs in the nasal cavity, thereby improving intranasal drug delivery.
Similar content being viewed by others
REFERENCES
Y. W. Chien. Transnasal Systemic Medications, Elsevier, Amsterdam, 1985.
Y. W. Chien, K. S. E. Su, and S. F. Chang. Nasal Systemic Drug Delivery, Marcel Dekker, New York, 1989.
D. R. Adams. Transitional epithelial zone of the bovine nasal mucosa. Am. J. Anat. 176:159–170 (1986).
M. Boysen. The surface structure of the human nasal mucosa. I. Ciliated and metaplastic epithelium in normal individuals. A correlated study by scanning/transmission electron and light microscopy. Virchows Arch. (Cell Pathol.) 40:279–294 (1982).
B. Petruson, H. A. Hansson, and G. Karlsson. Structural and functional aspects of cells in the nasal mucociliary system. Arch. Otolaryngol. 20:518–541 (1984).
P. Satir. The generation of ciliary motion. J. Protozool. 31:8–12 (1984).
A. Wanner. Clinical aspects of mucociliary transport. Am. Rev. Resp. Dis. 116:73–125 (1977).
G. S. M. J. E. Duchateau, K. Graamans, J. Zuidema, and F. W. H. M. Merkus. Correlation between nasal ciliary beat frequency and mucus transport rate in volunteers. Laryngoscope 95:854–859 (1985).
A. M. Lucas and L. C. Douglas. Principles underlying ciliary activity in the respiratory tract. Arch. Otolaryngol. 20:518–541 (1934).
P. Satir and M. A. Sleigh. The physiology of cilia and mucociliary interactions. Annu. Rev. Physiol. 52:137–155 (1990).
I. Andersen and D. F. Proctor. Measurement of nasal mucociliary clearance. Eur. J. Resp. Dis. 64 (Suppl. 127):37–40 (1983).
J. G. Hardy, S. W. Lee, and C. G. Wilson. Intranasal drug delivery by spray and drops. J. Pharm. Pharmacol. 37:294–297 (1985).
A. S. Harris, I. M. Nilsson, Z. G. Wagner, and U. Alkner. Intranasal administration of peptides: Nasal deposition, biological response, and absorption of desmopressin. J. Pharm. Sci. 75:1085–1088 (1986).
L. Illum, H. Jörgensen, H. Bisgaard, O. Krogsgaard, and N. Rossing. Bioadhesive microspheres as a potential nasal drug delivery system. Int. J. Pharm. 39:189–199 (1987).
K. Takeuchi, Y. Sakakura, S. Murai, and Y. Majima. Nasal mucociliary clearance in Sjögrens syndrome. Acta Otolaryngol. 108:126–129 (1989).
E. Puchelle, F. Aug, Q. T. Pham, and A. Bertrand. Comparison of three methods for measuring nasal mucociliary clearance in man. tActa Otolaryngol. 91:297–303 (1981).
M. F. Quinlan, S. D. Salman, D. L. Swift, H. N. Wagner Jr., and D. F. Proctor. Measurement of mucociliary function in man. Am. Rev. Resp. Dis. 99:13–23 (1969).
Y. S. Sakakura, Y. Sasaki, R. B. Hornick, Y. Togo, A. R. Schwartz, H. B. Wagner Jr., and D. F. Proctor. Mucociliary function during experimentally induced rhinovirus infection in man. Ann. Otol. 82:203–211 (1973).
I. B. Andersen, P. C. Camner, P. L. Jensen, K. Philipson, and D. F. Proctor. Nasal clearance in monozygotic twins. Am. Rev. Resp. Dis. 110:301–305 (1974).
H. Simon, B. Drettner, and B. Jung. Messung des Schleimhauttransportes in menschlichen Nase mit 51Cr markierten Harzkügelchen. Acta Otolanryngol. 83:378–389 (1977).
M. A. Sackner. Mucociliary transport. Ann. Otol. 87:474–483 (1978).
J. H. L. van Ree and H. A. E. van Dishoeck. Some investigations on nasal ciliary activity. Pract. Otorhinolaryng. 24:383–390 (1962).
D. Passali, L. Bellussi, M. Bianchini Ciampoli, and E. De Seta. Experiences in the determination of nasal mucociliary transport time. Acta Otolaryngol. 97:319–323 (1984).
D. Passali and M. Bianchini Ciampoli. Normal values of mucociliary transport time in young subjects. Int. J. Pedia. Otorhinolaryngol. 9:151–156 (1985).
H. J. M. van de Donk, A. G. M. van den Heuvel, J. Zuidema, and F. W. H. M. Merkus. The effect of nasal drops and their additives on human nasal mucociliary clearance. Rhinology 20:127–137 (1982).
Y. Sakakura, K. Ukai, Y. Majima, S. Murai, T. Harada, and Y. Miyoshi. Nasal mucociliary clearance under various conditions. Acta Otolaryngol. 96:167–173 (1983).
J. Rutland and P. J. Cole. Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared with sinusitis and bronchiectasis. Thorax 36:654–658 (1981).
C. Marriott. The viscoelastic nature of mucus secretion. Chest 80 (Suppl.):804–808 (1981).
K. T. Morgan, D. L. Patterson, and E. H. Gross. Frog palate mucociliary apparatus: Structure, function, and response to formaldehyde gas. Fund. Appl. Toxicol. 4:58–68 (1984).
H. Winet, G. T. Yates, T. Y. Wa, and J. Head. On the mechanisms of mucociliary flows III. Flow-velocity profiles in frog palate mucus. J. Appl. Physiol. Resp. Environ. Exercise Physiol. 56:785–794 (1984).
M. J. Dulfano and K. B. Adler. Physical properties of sputum. VII. Rheological properties and mucociliary transport. Am. Rev. Resp. Dis. 112:341–347 (1975).
E. Puchelle and J. M. Zahm. Influence of rheological properties of human bronchial secretions on the ciliary beat frequency. Biorheology 21:265–272 (1984).
Y. Majima, Y. Sakakura, T. Matsubara, Y. Hamaguchi, K. Hirata, K. Takeuchi, and Y. Miyoshi. Rheological properties of middle ear effusions from children with otitis media with effusion. Ann. Otorhinolaryngol. 95 (Suppl):1–4 (1986).
Y. Majima, M. Inagaki, K. Hirata, K. Takeuchi, A. Morishita, and Y. Sakakura. The effect of an orally administered proteolytic enzyme on the elasticity and viscosity of nasal mucus. Arch. Otorhinolaryngol. 244:355–359 (1988).
H. J. M. van de Donk, J. Zuidema, and F. W. H. M. Merkus. The influence of the pH and osmotic pressure upon tracheal ciliary beat frequency as determined with a new photoelectric registration device. Rhinology 18:93–104 (1980).
U. Mercke, C. H. Håkansson, and N. G. Toremalm. A method for standardized studies of mucociliary activity. Acta Otolaryngol. 78:118–123 (1974).
J. C. Hybbinette and U. Mercke. A method for evaluating the effect of pharmacological substances on mucociliary activity in vitro. Acta Otolaryng. 93:151–159 (1982).
W. I. Lee and P. Verdugo. Ciliary activity by laser light scattering spectroscopy. J. Appl. Physiol. Ann. Biomed. Eng. 5:248–259 (1977).
L. B. Wong, I. F. Miller, and D. B. Yeates. Stimulation of ciliary beat frequency by autonomic agonists: In vivo. J. Appl. Physiol. 65:971–981 (1988).
T. Dalhamn. A method for determination in vivo of the rate of ciliary beat and mucus flow in the trachea. Ada Physiol. Scand. 33:1–5 (1955).
S. J. Hennessey, L. B. Wong, D. B. Yeates, and I. F. Miller. Automated measurement of ciliary beat frequency. J. Appl. Physiol. 60:2109–2113 (1986).
T. Dalhamn and R. Rylander. Frequency of ciliary beat measured with a photo-sensitive cell. Nature 196:592–593 (1962).
J. Yager, T. M. Chen, and M. J. Dulfano. Measurement of frequency of ciliary beats of human respiratory epithelium. Chest 73:627–633 (1978).
D. Eshel, Y. Grossman, and Z. Priel. Spectral characterization of ciliary beating: variations of frequency with time. Am. J. Physiol. 249 (Cell Physiol. 18):C160–C165 (1985).
P. C. Braga, G. D. Oglio, R. Bossi, and L. Allegra. Simple and precise method for counting ciliary beats directly from the TV monitor screen. J. Pharmacol. Methods 16:161–169 (1986).
H. Teichtal, P. L. Wright, and R. L. G. Kirsner. Measurement of in vitro ciliary beat frequency: A television-video modification of the transmitted light technique. Med. Biol. Eng. Comput. 24:193–196 (1986).
J. Hee and R. Guillerm. Discussion on smoke and mucociliary transport. Eur. J. Resp. Dis. 66 (Suppl. 139):86–88 (1985).
K. Ukai, Y. Sakakura, and S. Saida. Interaction between mucociliary transport and the ciliary beat of chicken nasal mucosa. Arch. Otolaryngol. 242:255–231 (1985).
H. Lioté, J. M. Zahm, D. Pierrot, and E. Puchelle. Role of mucus and cilia in nasal mucociliary clearance in healthy subjects. Am. J. Resp. Dis. 140:132–136 (1989).
C. K. Luk and M. J. Dulfano. Effect of pH, viscosity, and ionic strength changes on ciliary beat frequency of human bronchial explants. Clin. Sci. 64:449–451 (1983).
W. A. J. J. Hermens and F. W. H. M. Merkus. The influence of drugs on nasal ciliary movement. Pharm. Res. 4:445–449 (1987).
D. Pavia, P. P. Sutton, M. T. Lopez-Vidriero, J. E. Agnew, and S. W. Clarke. Drug effects on mucociliary function. Eur. J. Resp. Dis. 64 (Suppl. 128):304–317 (1983).
H. J. M. van de Donk, S. Jadoenath, J. Zuidema, and F. W. H. M. Merkus. The effects of drugs on ciliary motility I. Decongestants. Int. J. Pharm. 12:57–65 (1982).
H. J. M. van de Donk, A. L. M. van Egmond, J. Zuidema, and F. W. H. M. Merkus. The effects of drugs on ciliary motility II. Antimicrobial agents. Int. J. Pharm. 12:67–76 (1982).
H. J. M. van de Donk, A. L. M. van Egmond, A. G. M. van den Heuvel, J. Zuidema, and F. W. H. M. Merkus. The effects of drugs on ciliary motility. III. Local anaesthetics and antiallergic drugs. Int. J. Pharm. 12:77–85 (1982).
H. J. M. van de Donk, J. Zuidema, and F. W. H. M. Merkus. The effects of nasal drops on the ciliary beat frequency of chicken embryo tracheas. Rhinology 19:215–230 (1981).
H. J. M. van de Donk, I. P. Muller-Plantema, J. Zuidema, and F. W. H. M. Merkus. The effects of preservatives on the ciliary beat frequency of chicken embryo tracheas. Rhinology 18:119–133 (1981).
A. H. Batts, C. Marriott, G. P. Martin, and S. W. Bond. The effect of some preservatives used in nasal preparations on mucociliary clearance. J. Pharm. Pharmacol. 41:156–159 (1989).
A. H. Batts, C. Marriott, G. P. Martin, C. F. Wood, and S. W. Bond. The effect of some preservatives used in nasal preparations on the mucus and ciliary components of mucociliary clearance. J. Pharm. Pharmacol. 42:145–151 (1990).
J. Levrier, S. Molon-Noblot, D. Duval, and K. G. Lloyd. A new ex vivo method for the study of nasal drops on ciliary function. Fund. Clin. Pharmacol. 3:471–482 (1989).
S. Hirai, T. Yashiki, and H. Mima. Mechanisms for the enhancement of the nasal absorption of insulin by surfactants. Int. J. Pharm. 9:173–184 (1981).
A. E. Pontirolli, M. Alberetto, A. Secchi, G. Dossi, I. Bosi, and G. Pozza. Insulin given intranasally induces hypoglycemia in normal and diabetic subjects. Br. Med. J. 284:303–306 (1982).
A. C. Moses, J. S. Flier, G. S. Gordon, R. D. Silver, and M. C. Carey. Transnasal insulin delivery: Structure-function studies of absorption enhancing adjuvants. Clin. Res. 32:245A (1984).
G. S. M. J. E. Duchateau, J. Zuidema, and F. W. H. M. Merkus. Bile salts and intranasal drug delivery. Int. J. Pharm. 31:193–199 (1986).
J. P. Longenecker, A. C. Moses, J. S. Flier, R. D. Silver, M. C. Carey, and E. J. Dubovi. Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep. J. Pharm. Sci. 76:351–355 (1987).
M. J. M. Deurloo, W. A. J. J. Hermens, S. G. Romeyn, J. C. Verhoef, and F. W. H. M. Merkus. Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate in rabbits and rats. Pharm. Res. 6:853–856 (1990).
W. A. J. J. Hermens, P. M. Hooymans, J. C. Verhoef, and F. W. H. M. Merkus. Effects of absorption enhancers on human nasal tissue ciliary movement in vitro. Pharm. Res. 7:144–146 (1990).
G. P. Martin, C. Marriott, and I. W. Kellaway. Direct effect of bile salts and phopholipids on the physical properties of mucus. Gut 19:103–107 (1978).
L. Öhman, R. Hahnenberger, and E. D. B. Johansson. 17β-Estradiol levels in blood and cerebrospinal fluid after ocular and nasal administration in women and female rhesus monkeys (Macaca mulatta). Contraception 22:349–385 (1980).
R. N. Bawarshi-Nassar, A. A. Hussain, and P. A. Crooks. Nasal absorption and metabolism of progesterone and 17β-estradiol in the rat. Drug Metab. Dispos. 17:248–254 (1989).
W. A. J. J. Hermens, M. J. M. Deurloo, S. G. Romeyn, J. C. Verhoef, and F. W. H. M. Merkus. Nasal absorption enhancement of 17β-estradiol by dimethyl-β-cyclodextrin in rabbits and rats. Pharm. Res. 7:500–503 (1990).
N. G. M. Schipper, W. A. J. J. Hermens, S. G. Romeyn, J. Verhoef, and F. W. H. M. Merkus. Nasal absorption of 17β-estradiol and progesterone from a dimethyl-β-cyclodextrin inclusion formulation in rats. Int. J. Pharm. 64:61–66 (1990).
K. Uekama. Cyclodextrin inclusion compounds: Effects on stability and biopharmaceutical properties. In D. D. Breimer and P. Speiser (eds.), Topics in Pharmaceutical Sciences, Elsevier, Amsterdam, 1987, pp. 181–194.
K. Uekama, T. Fujinaga, F. Hirayama, M. Otagiri, and M. Yamasaki. Inclusion complexation of steroid hormones with cyclodextrins in water and in solid phase. Int. J. Pharm. 10:1–15 (1982).
W. A. J. J. Hermens, C. W. J. Belder, J. M. W. M. Merkus, P. M. Hooymans, J. Verhoef, and F. W. H. M. Merkus. Intranasal estradiol administration to oophorectomized women. Eur. J. Obstet. Gynecol. Reprod. Biol. 40:35–41 (1991).
F. W. H. M. Merkus, J. Verhoef, S. G. Romijn, and N. G. M. Schipper. Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats. Pharm. Res. 8:588–592 (1991).
K. Uekama and M. Otagiri. Cyclodextrins in drug carrier systems. CRC Crit. Rev. Ther. Drug Carrier Syst. 3:1–40 (1980).
S. Gizurarson. Animal models for intranasal drug delivery studies. Acta Pharm. Nor. 2:105–122 (1990).
F. Y. Aoki and J. C. W. Crawley. Distribution and removal of human serum albumin-technetium-99m instilled intranasally. Br. J. Clin. Pharmacol. 3:869–878 (1976).
N. Mygind. Nasal Allergy, 2nd ed., Alden Press, Oxford, 1979, pp. 257–270.
A. S. Harris, E. Svensson, Z. G. Wagner, S. Lethagen, and I. M. Nilsson. Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin. J. Pharm. Sci. 77:405–408 (1988).
A. S. Harris, M. Ohlin, E. Svensson, S. Lethagen, and I. M. Nilsson. Effect of viscosity on the pharmacokinetics and biological response to intranasal desmopressin. J. Pharm. Sci. 78:470–471 (1989).
A. K. Pennington, J. H. Ratcliffe, C. G. Wilson, and J. G. Hardy. The influence of solution viscosity on nasal spray deposition and clearance. Int. J. Pharm. 43:221–224 (1988).
L. Ilium, N. F. Farraj, H. Critchley, and S. S. Davis. Nasal administration of gentamicin using a novel microsphere delivery system. Int. J. Pharm. 46:261–265 (1988).
E. Björk and P. Edman. Characterization of degradable starch microspheres as a nasal delivery system for drugs. Int. J. Pharm. 62:187–192 (1990).
N. F. Farraj, B. R. Johansen, S. S. Davis, and L. Illum. Nasal administration of insulin using bioadhesive microspheres as a delivery system. J. Control. Rel. 13:253–261 (1990).
K. Morimoto, K. Morisaka, and A. Kamada. Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel. J. Pharm. Pharmacol. 37:134–136 (1985).
T. Nagai, J. Nishimoto, N. Nambu, Y. Suzuki, and K. Sekine. Powder dosage form of insulin for nasal administration. J. Control. Rel. 1:15–22 (1984).
I. Gonda and E. Gipps. Model of disposition of drugs administered into the human nasal cavity. Pharm. Res. 7:69–75 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schipper, N.G.M., Verhoef, J.C. & Merkus, F.W.H.M. The Nasal Mucociliary Clearance: Relevance to Nasal Drug Delivery. Pharm Res 8, 807–814 (1991). https://doi.org/10.1023/A:1015830907632
Issue Date:
DOI: https://doi.org/10.1023/A:1015830907632